25 studies found for:    " April 27, 2011":" May 27, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" April 27, 2011":" May 27, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (25 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients
Condition: Human Immunodeficiency Virus (HIV) Infection
Intervention: Drug: Etravirine
2 Completed Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth
Conditions: Patient Adherence;   HIV
Intervention: Behavioral: SMS Text Message Reminder
3 Recruiting Treatment Advocacy Intervention for HIV-Positive African Americans
Condition: HIV
Intervention: Behavioral: Treatment Advocacy
4 Active, not recruiting Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: EVG/COBI/FTC/TDF;   Drug: COBI;   Drug: ATV;   Drug: DRV;   Drug: NRTI
5 Recruiting Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
Conditions: Hepatitis;   HIV;   Liver Cancer
Intervention:
6 Active, not recruiting Switch to Unboosted Atazanavir With Tenofovir Study
Condition: HIV Infection
Interventions: Drug: atazanavir;   Drug: atazanavir/ritonavir
7 Completed Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring
Condition: HIV Infections
Interventions: Drug: Dapivirine Vaginal Ring;   Drug: Maraviroc Vaginal Ring;   Other: Placebo Vaginal Ring;   Drug: Dapivirine-Maraviroc Vaginal Ring
8 Completed Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected Patients
Condition: HIV Infection
Intervention:
9 Recruiting Traditional Complementary and Alternative Medicine (CAM) Therapy in the Treatment of HIV/AIDS
Condition: HIV Infections
Intervention: Drug: "Kallunk oxide (Immunotherapy) "
10 Recruiting A Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIV
Conditions: HIV Infection;   Substance Abuse
Interventions: Behavioral: Trans-theoretical Process of Change Model-self;   Behavioral: Trans-theoretical Process of Change Model - interviewer
11 Active, not recruiting Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study
Conditions: Visceral Leishmaniosis;   HIV-infection/Aids
Intervention: Drug: Pentamidine
12 Recruiting Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients
Conditions: HIV-1 Infection;   AIDS
Interventions: Drug: Maraviroc (Celsentri);   Drug: Placebo
13 Completed Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome
Condition: HIV-Associated Lipodystrophy Syndrome
Intervention:
14 Completed Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023
Condition: Human Immunodeficiency Virus
Interventions: Drug: KM-023;   Drug: Placebo for KM-023
15 Active, not recruiting Human Immune Responses Toward HIV-1 Envelope Antigens
Condition: HIV Infection
Intervention:
16 Terminated Study of MK-1972 in Human Immunodeficiency Virus (HIV)-1 Infected Participants Who Have Not Previously Received Antiretroviral Therapy (MK-1972-003)
Condition: HIV-1 Infection
Interventions: Drug: MK-1972;   Drug: Placebo to MK-1972
17 Completed Dolutegravir Renal Impairment Study
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Dolutegravir 50 mg
18 Completed Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg;   Drug: Dolutegravir 50 mg;   Drug: abacavir 600 mg/lamivudine 300 mg
19 Unknown  Efficacy of Drug and Risk Counseling Among Methadone Patients in Jakarta, Indonesia
Conditions: HIV Risk Behaviors;   Heroin Injection;   Retention in Methadone Treatment
Interventions: Behavioral: Behavioral Drug and Risk Counseling (BDRC);   Behavioral: methadone maintenance treatment
20 Recruiting Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder
Condition: HIV Associated Neurocognitive Disorder
Interventions: Drug: Fluconazole;   Drug: Paroxetine;   Drug: Paroxetine and Fluconazole;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-25) Show next page of results
Indicates status has not been verified in more than two years